Subscribe To
ISRG / Wall Street Loves These 3 Growth Stocks; Should You?
ISRG News
By Zacks Investment Research
November 3, 2023
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that more_horizontal
By The Motley Fool
October 21, 2023
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?
Intuitive Surgical reported third-quarter results on Thursday after U.S. markets closed. Sales rose year over year, but contracted slightly compared t more_horizontal
By InvestorPlace
October 20, 2023
Invest in the Robot Takeover: 3 Stocks to Buy Before They Skyrocket
The AI boom, exemplified by companies like OpenAI and the success of generative text models like ChatGPT, was rapid, but I see challenges ahead. The A more_horizontal
By Barrons
October 20, 2023
Intuitive Surgical Sees Robot Procedures Slow. Blame Wegovy and Ozempic for Now.
Intuitive's bariatric surgeries have slowed due to weight-loss drugs, but the company doesn't see a lasting effect. more_horizontal
By Zacks Investment Research
October 20, 2023
Intuitive Surgical (ISRG) Q3 Earnings Beat, Procedures Robust
Intuitive Surgical's (ISRG) third-quarter results reflect healthy demand for procedures, partially offset by lower system sales. Higher pricing booste more_horizontal
By Seeking Alpha
October 19, 2023
Intuitive Surgical, Inc. (ISRG) Q3 2023 Earnings Call Transcript
Intuitive Surgical, Inc. (ISRG) Q3 2023 Earnings Call Transcript more_horizontal
By Zacks Investment Research
October 19, 2023
Here's What Key Metrics Tell Us About Intuitive Surgical, Inc. (ISRG) Q3 Earnings
The headline numbers for Intuitive Surgical, Inc. (ISRG) give insight into how the company performed in the quarter ended September 2023, but it may b more_horizontal
By Proactive Investors
October 19, 2023
Intuitive Surgical shares tumble on disappointing 3Q revenue
Intuitive Surgical (NASDAQ:ISRG) shares dropped nearly 8% in extended trading Thursday after the company's quarterly revenue fell short of expectation more_horizontal